Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06653946
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-04
Brief Title:
Impact of AF on Post-alteplase HT
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Different Subtypes of AF on Post-alteplase HT
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction
Detailed Description:
Investigators conducted a prospective cohort study between July 2021 and July 2023 They screened 1550 patients who presented with AIS and received alteplase and included 716 AIS patients who met the inclusion criteria and were diagnosed based on a thorough clinical assessment including a detailed medical history physical examination and specific brain imaging results and treated with alteplase within four and half hours of stroke onset
The investigators assessed the patients follow-up brain imaging to detect the subtypes of hemorrhagic transformation after receiving alteplase
The study consisted of two distinct groups The first group consisted of 454 patients who did not experience hemorrhagic infarction while the second group comprised 262 patients who experienced hemorrhagic infarction
The investigators evaluated whether the characteristics of ischemic stroke patients door-to-needle time and stroke risk factors different types of AF were predictive variables for different subtypes of post-alteplase hemorrhagic transformation of brain infarction
The investigators assessed the patients follow-up brain imaging to detect the subtypes of hemorrhagic transformation after receiving alteplase
The study consisted of two distinct groups The first group consisted of 454 patients who did not experience hemorrhagic infarction while the second group comprised 262 patients who experienced hemorrhagic infarction
The investigators evaluated whether the characteristics of ischemic stroke patients door-to-needle time and stroke risk factors different types of AF were predictive variables for different subtypes of post-alteplase hemorrhagic transformation of brain infarction
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None